Lv1
58 积分 2024-12-22 加入
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
1个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1个月前
已完结
Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care
1个月前
已关闭
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
1个月前
已完结
Intratumoral bacterium Enterocloster bolteae promotes hepatocellular carcinoma progression by directly binding tumor cells
5个月前
已完结
The gut microbiome and cancer: from tumorigenesis to therapy
5个月前
已完结
Targeting systemic and gut microbial metabolism in ER+ breast cancer
10个月前
已完结
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis
1年前
已完结
Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline†
1年前
已完结
皖公网安备34019202002308
